Clinical trials
6 active studies led by Urotronic Inc., of 10 in all
Source: ClinicalTrials.gov, Studies with Urotronic Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show Urotronic Inc. in 2 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Urotronic Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
6 active studies led by Urotronic Inc., of 10 in all
Source: ClinicalTrials.gov, Studies with Urotronic Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
4 510(k) clearances and PMA approvals since 2015
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
Studies Urotronic Inc. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Urotronic Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Urotronic Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Urotronic Inc. is in.
Stories on the topics Urotronic Inc. works in.
Only about a quarter of testosterone booster products had study data showing they raise testosterone. Sexual…
Read
Omega-3 supplements are hugely popular. Big trials give mixed answers on whether they protect the heart.
Read
About 1 in 6 adults experience infertility. In many countries one IVF cycle costs more than a year's income.
Read